Evidence map›Paper›PMID 29932504›Full record

ArticlePhysiological reports2018

mTORc1 activity is necessary and sufficient for phosphorylation of eNOS

Brandee Decker, Kevin Pumiglia

Open access · goldAbstract read
In one paragraph

Article in Physiological reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Brandee DeckerDepartment of Regenerative and Cancer Cell Biology, Albany Medical College, Albany, New York.
Kevin PumigliaDepartment of Regenerative and Cancer Cell Biology, Albany Medical College, Albany, New York.ORCID 0000-0003-4655-0334
Albany Medical Center Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nitric oxide, produced by eNOS, plays critical roles in the regulation of vascular function and maintenance. Chronic PI3K signaling has recently been associated with vascular malformations. A well described substrate downstream of PI3K signaling is eNOS. Another critical downstream target of PI3K is the metabolic regulator, mTORc1. The relationship between mTORc1 and eNOS regulation, has not been determined. We generated cells with manipulated PI3K signaling by expressing the activating mutation, PIK3CA

Indexed as

Cells, CulturedClass I Phosphatidylinositol 3-KinasesEndothelial CellsEnzyme ActivationHumansMechanistic Target of Rapamycin Complex 1Nitric Oxide Synthase Type IIIPhosphatidylinositol 3-KinasesPhosphorylationRas Homolog Enriched in Brain ProteinClass I Phosphatidylinositol 3-KinasesMechanistic Target of Rapamycin Complex 1Nitric Oxide Synthase Type IIINOS3 protein, humanPhosphatidylinositol 3-KinasesPIK3CA protein, humanRas Homolog Enriched in Brain ProteinRHEB protein, humanEndothelial cellendothelial nitric oxide synthasemammalian target of rapamycinphosphatidylinositide 3-kinaserapamycinras homolog expressed in brain

Identifiers

PMID29932504
PMCPMC6014452
OpenAlexW2809417306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.